Verona Pharma PLC (VRNA)
38.18
+3.20
(+9.15%)
USD |
NASDAQ |
Nov 04, 16:00
38.30
+0.12
(+0.31%)
After-Hours: 20:00
Verona Pharma Total Liabilities (Quarterly): 265.85M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 265.85M |
| March 31, 2024 | 64.92M |
| December 31, 2023 | 58.84M |
| September 30, 2023 | 28.94M |
| June 30, 2023 | 30.84M |
| March 31, 2023 | 46.40M |
| December 31, 2022 | 29.00M |
| September 30, 2022 | 37.39M |
| June 30, 2022 | 43.98M |
| March 31, 2022 | 43.01M |
| December 31, 2021 | 38.58M |
| September 30, 2021 | 33.36M |
| June 30, 2021 | 64.10M |
| March 31, 2021 | 17.74M |
| December 31, 2020 | 19.35M |
| September 30, 2020 | 48.11M |
| June 30, 2020 | 40.72M |
| March 31, 2020 | 12.42M |
| December 31, 2019 | 13.49M |
| September 30, 2019 | 17.54M |
| June 30, 2019 | 13.77M |
| March 31, 2019 | 9.242M |
| December 31, 2018 | 14.37M |
| September 30, 2018 | 14.94M |
| June 30, 2018 | 18.09M |
| Date | Value |
|---|---|
| March 31, 2018 | 24.26M |
| December 31, 2017 | 13.00M |
| September 30, 2017 | 12.97M |
| June 30, 2017 | 11.78M |
| December 31, 2016 | 14.40M |
| June 30, 2016 | 1.688M |
| June 30, 2016 | 1.688M |
| December 31, 2015 | 3.566M |
| June 30, 2015 | 0.8983M |
| June 30, 2015 | 0.8983M |
| December 31, 2014 | 0.8161M |
| June 30, 2014 | 0.6904M |
| June 30, 2014 | 0.6904M |
| December 31, 2013 | 0.8069M |
| June 30, 2013 | 0.2653M |
| June 30, 2013 | 0.2653M |
| December 31, 2012 | 0.3221M |
| June 30, 2012 | 0.1571M |
| June 30, 2012 | 0.1571M |
| December 31, 2011 | 0.2422M |
| June 30, 2011 | 0.4597M |
| December 31, 2010 | 0.3179M |
| June 30, 2010 | 0.0978M |
| December 31, 2009 | 0.4641M |
| June 30, 2009 | 0.0938M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.42M
Minimum
Mar 2020
265.85M
Maximum
Jun 2024
49.32M
Average
38.58M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 225.43M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| NuCana PLC | 20.58M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Autolus Therapeutics PLC | 325.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 434.12M |
| Shareholders Equity (Quarterly) | 168.27M |